Individualized Timing of Analgesia and Effectiveness of Labor Analgesia

Sponsor
Peking University First Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT02920489
Collaborator
(none)
200
1
2
11
18.2

Study Details

Study Description

Brief Summary

Neuraxial analgesia is the gold standard to relieve labor pain. A recent "Practice guidelines for obstetric anesthesia" suggests that neuraxial analgesia should be provided in the early stage of labor (cervical dilation < 5 cm) or on a individualized basis. The purpose of this randomized controlled trial is to investigate whether neuraxial labor analgesia administered on an individualized basis can improve analgesia quality and maternal satisfaction.

Condition or Disease Intervention/Treatment Phase
  • Drug: Individualized epidural analgesia
  • Drug: Routine epidural analgesia
N/A

Detailed Description

Neuraxial analgesia is the gold standard to relieve labor pain. It also helps to attenuate maternal anxiety and improve maternal satisfaction. A recent "Practice guidelines for obstetric anesthesia" suggests that neuraxial analgesia should be provided in the early stage of labor (cervical dilation < 5 cm) or, for some special patients, be provided on a individualized basis. Studies showed that, when compared with late administration, early administration of labor analgesia resulted in equivocal findings for spontaneous, instrumented, and cesarean delivery. The investigators hypothesize that neuraxial labor analgesia provided on an individualized basis will further improve analgesia quality and maternal satisfaction. The purpose of this randomized controlled trial is to investigate whether neuraxial labor analgesia administered on an individualized basis can improve analgesia quality and maternal satisfaction.

Study Design

Study Type:
Interventional
Actual Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Impact of Individualized Timing of Analgesia on the Effectiveness of Labor Analgesia: a Randomized Controlled Trial
Actual Study Start Date :
Aug 1, 2016
Actual Primary Completion Date :
Jun 1, 2017
Actual Study Completion Date :
Jul 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Individualized epidural analgesia

Epidural catheterization will be performed after the beginning of the first stage of labor. Epidural analgesia will begin when asked by parturients and the numeric rating scale of pain is 5 or higher. A loading dose (10 ml mixture of 0.1% ropivacaine and 0.5 ug/ml sufentanil) will be administered through the epidural catheter. After a 20-minute observation, a patient-controlled analgesia pump (containing a mixture of 0.08% ropivacaine and 0.4 ug/ml sufentanil) will be connected to the epidural catheter and programmed to deliver a 6-ml bolus with a 20-minute lockout interval and a 4 ml/h background infusion. Analgesia will be terminated at the end of the third stage of labor.

Drug: Individualized epidural analgesia
Epidural analgesia will begin when asked by the parturients (during the first stage of labor) and the numeric rating scale is 5 or higher. Analgesia will be terminated at the end of the third stage of labor.
Other Names:
  • Individualized analgesia with sufentanil and ropivacaine
  • Active Comparator: Routine epidural analgesia

    Epidural catheterization will be performed after the beginning of the first stage of labor and the cervix is dilated to 1 cm or more. Epidural analgesia will then begin. A loading dose (10 ml mixture of 0.1% ropivacaine and 0.5 ug/ml sufentanil) will be administered through the epidural catheter. After a 20-minute period observation, a patient-controlled analgesia pump (containing a mixture of 0.08% ropivacaine and 0.4 ug/ml sufentanil) will be connected to the epidural catheter and programmed to deliver a 6-ml bolus with a 20-minute lockout interval and a 4 ml/h background infusion. Analgesia will be terminated at the end of the third stage of labor.

    Drug: Routine epidural analgesia
    Epidural analgesia will begin when asked by the parturients (during the first stage of labor) and the cervix is dilated to 1 cm or more. Analgesia will be terminated at the end of the third stage of labor.
    Other Names:
  • Routine analgesia with sufentanil and ropivacaine
  • Outcome Measures

    Primary Outcome Measures

    1. The most severe labor pain score during labor [Assessed at 24 hours after delivery]

      Assessed with numeric rating scale, where 0 indicates no pain and 10 the worst pain.

    Secondary Outcome Measures

    1. Incidence of instrumental delivery [At the time of delivery]

      Incidence of instrumental delivery

    2. Incidence of Cesarean delivery [At the time of delivery]

      Incidence of Cesarean delivery

    3. Neonatal Apgar score [At 1 and 5 minutes after delivery]

      Neonatal Apgar score

    4. Maternal satisfaction with labor analgesia [Assessed at 24 hours after delivery]

      Assessed with the Likert scale, where 1=extremely dissatisfaction, 2=dissatisfaction, 3=neither dissatisfaction nor satisfaction, 4=satisfaction, 5=extremely satisfaction.

    5. Persistent pain score at 24 hours and 42 days after delivery [At 24 hours and 42 days after delivery]

      Assessed with numeric rating scale, where 0 indicates no pain and 10 the worst pain.

    6. Rate of breast-feeding [At 24 hours and 42 days after delivery]

      Rate of breast-feeding

    7. Incidence of postpartum depression [At 42 days after delivery]

      Postpartum depression will be diagnosed as Edinburgh postnatal depression scale of 10 or higher.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 36 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Nulliparas (aged 18-36 years) with single cephalic term pregnancy;

    2. Plan to deliver vaginally, and are considered suitable for a trial of vaginal delivery by obstetricians;

    3. Admitted to the delivery room;

    4. Agree to receive epidural analgesia during labor.

    Exclusion Criteria:
    1. History of psychiatric disease (indicate those that are diagnosed before or during pregnancy by psychiatrists);

    2. Presence of contraindications to epidural analgesia, which includes: (1) History of infectious disease of the central nervous system (poliomyelitis, cerebrospinal meningitis, encephalitis, etc.); (2) History of spinal or intra-spinal disease (trauma or surgery of spinal column, intra-spinal canal mass, etc.); (3) Systemic infection (sepsis); (4) Skin or soft tissue infection at the site of epidural puncture; (5) Coagulopathy.

    3. Other reasons that are considered unsuitable for study participation.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Peking University First Hospital Beijing Beijing China 100034

    Sponsors and Collaborators

    • Peking University First Hospital

    Investigators

    • Principal Investigator: Dong-Xin Wang, MD, PhD, Peking University First Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Dong-Xin Wang, Professor and Chairman, Department of Anesthesiology and Critical Care Medicine, Peking University First Hospital
    ClinicalTrials.gov Identifier:
    NCT02920489
    Other Study ID Numbers:
    • 2016[1094]
    • ChiCTR-IPR-16007976
    First Posted:
    Sep 30, 2016
    Last Update Posted:
    Jul 19, 2017
    Last Verified:
    Jul 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by Dong-Xin Wang, Professor and Chairman, Department of Anesthesiology and Critical Care Medicine, Peking University First Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 19, 2017